Northwest Biotherapeutics, Inc.: A Second-Generation Dendritic Cell Cancer Vaccine Preparing to Shine

Thursday November 15, 2018 | by Michael Bigger |

Read More
Previous
Previous

ClearPoint Neuro, Inc.: Unleashing the 2017 Adjacent Possible into Reality - NOW! 

Next
Next

100 to 1 - MRI Interventions, Inc.